The causes of the notifiable fowl plague are high and low pathogenic avian influenza A viruses of the haemagglutinin subtypes H5 and H7 but also other haemagglutinin subtypes If the intravenous pathogenicity index is greater than 1.2. The German fowl plague order (Geflügelpest-Verordnung) differentiates between highly pathogenic influenza A viruses of the subtypes H5 and H7, if multiple basic amino acids at the cleavage site of the haemagglutinin molecules are detected by virus isolation, antigen or genome determination and low pathogenic avian influenza A viruses of the subtypes H5 and H7 if either the intravenous pathogenicity index is lower than 1.2 or no basic amino acids are present at the cleavage site of the haemagglutinin molecule. Aspects of diagnosis, control including culling, therapy and vaccination are reviewed. The currently available means and their limitations of a therapy of fowl plague by oral administration of neuraminidase inhibitors (e. g. oseltamivir) are described. Following granted permission, individually marked valuable zoo and pet birds may be vaccinated using licensed inactivated vaccines. Vector vaccines have not been used in Germany so far. Avian influenza A viruses of other haemagglutinin subtypes (H1-H4, H6, H8-H18) may also cause infections and severe disease. These subtypes are not subject to governmental interventions and disease can be prevented by timely use of inactivated vaccines.
【저자키워드】 oseltamivir, therapy, Vaccines, Epidemiology, Diagnosis, pathogenicity, fowl plague,